• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类固醇倍氯米松以浓度依赖的方式改变含有蛋白质的肺表面活性剂单层。

The steroid mometasone alters protein containing lung surfactant monolayers in a concentration-dependent manner.

机构信息

School of Mechanical and Mechatronic Engineering, University of Technology Sydney, 15 Broadway, Ultimo, NSW, 2007, Australia.

School of Life Sciences, University of Technology Sydney, 15 Broadway, Ultimo, NSW, 2007, Australia.

出版信息

J Mol Graph Model. 2022 Mar;111:108084. doi: 10.1016/j.jmgm.2021.108084. Epub 2021 Nov 20.

DOI:10.1016/j.jmgm.2021.108084
PMID:34826717
Abstract

Mometasone is an investigational anti-inflammatory steroidal drug to treat inflammation via pulmonary administration. For steroid drugs to be effective they need to be adsorbed by lung surfactants, a thin monolayer at the air-water interface in alveoli that reduces surface tension. Information on the molecular-level interactions of the drug with lung surfactants is useful to understand the mechanism of adsorption. In this study, we use coarse-grained molecular dynamics simulation to understand the concentration-dependent effect of mometasone on a lung surfactant monolayer (LSM) composed of lipids and surfactant proteins, under two different breathing conditions (exhalation, at surface tension 0 mNm and inhalation, surface tension 20-25 mNm). A series of fixed-APL and fixed-surface tension simulations were used to demonstrate that in the absence of drugs, the model LSM reproduces the surface tensions for the compressed and expanded states, as well as compressibility at different surface tensions. In-depth analysis of simulations of a LSM in the presence of five different drug concentrations shows that mometasone alters the structure and dynamics of the LSM in a concentration-dependent manner. Mometasone induces a collapse in the monolayer that is affected by the surfactant protein and surface tension. Overall, these findings suggest that the surfactant proteins, surface tension and drug concentration are all critical components affecting monolayer stability and drug adsorption. The outcomes of this study may be beneficial for a more in-depth understanding of how mometasone is adsorbed by lung surfactants.

摘要

莫米松是一种研究中的抗炎类固醇药物,通过肺部给药来治疗炎症。为了使类固醇药物有效,它们需要被肺表面活性剂吸附,肺表面活性剂是肺泡中空气-水界面的一层薄的单层,可降低表面张力。关于药物与肺表面活性剂之间分子水平相互作用的信息有助于理解吸附机制。在这项研究中,我们使用粗粒化分子动力学模拟来了解莫米松在两种不同呼吸条件(呼气,表面张力为 0 mNm 和吸气,表面张力为 20-25 mNm)下对由脂质和表面活性剂蛋白组成的肺表面活性剂单层(LSM)的浓度依赖性影响。一系列固定 APL 和固定表面张力模拟用于证明在没有药物的情况下,模型 LSM 再现了压缩和扩展状态的表面张力以及不同表面张力下的可压缩性。在存在五种不同药物浓度的 LSM 的模拟的深入分析表明,莫米松以浓度依赖的方式改变 LSM 的结构和动力学。莫米松诱导单层坍塌,这受表面活性剂蛋白和表面张力的影响。总体而言,这些发现表明表面活性剂蛋白、表面张力和药物浓度都是影响单层稳定性和药物吸附的关键因素。这项研究的结果可能有助于更深入地了解莫米松如何被肺表面活性剂吸附。

相似文献

1
The steroid mometasone alters protein containing lung surfactant monolayers in a concentration-dependent manner.类固醇倍氯米松以浓度依赖的方式改变含有蛋白质的肺表面活性剂单层。
J Mol Graph Model. 2022 Mar;111:108084. doi: 10.1016/j.jmgm.2021.108084. Epub 2021 Nov 20.
2
Drug Meets Monolayer: Understanding the Interactions of Sterol Drugs with Models of the Lung Surfactant Monolayer Using Molecular Dynamics Simulations.药物与单层相遇:使用分子动力学模拟了解固醇类药物与肺表面活性剂单层模型的相互作用。
Methods Mol Biol. 2022;2402:103-121. doi: 10.1007/978-1-0716-1843-1_9.
3
Concentration-Dependent Effect of the Steroid Drug Prednisolone on a Lung Surfactant Monolayer.类固醇药物泼尼松龙对肺表面活性剂单层的浓度依赖性效应。
Langmuir. 2022 Apr 12;38(14):4188-4199. doi: 10.1021/acs.langmuir.1c02817. Epub 2022 Mar 28.
4
The concentration-dependent effect of hydrocortisone on the structure of model lung surfactant monolayer by using an approach.采用一种方法研究氢化可的松对模型肺表面活性剂单层结构的浓度依赖性效应。
RSC Adv. 2022 Nov 22;12(51):33313-33328. doi: 10.1039/d2ra05268g. eCollection 2022 Nov 15.
5
Shape matters-the interaction of gold nanoparticles with model lung surfactant monolayers.形状很重要——金纳米颗粒与模型肺表面活性剂单层的相互作用。
J R Soc Interface. 2021 Oct;18(183):20210402. doi: 10.1098/rsif.2021.0402. Epub 2021 Oct 13.
6
Molecular dynamics study of the effect of cholesterol on the properties of lipid monolayers at low surface tensions.胆固醇对低表面张力下脂质单分子层性质影响的分子动力学研究
Phys Chem Chem Phys. 2009 Mar 28;11(12):1916-22. doi: 10.1039/b819767a. Epub 2009 Feb 18.
7
Computer simulations of lung surfactant.肺表面活性剂的计算机模拟
Biochim Biophys Acta. 2016 Oct;1858(10):2431-2440. doi: 10.1016/j.bbamem.2016.02.030. Epub 2016 Feb 27.
8
Molecular insights on the interference of simplified lung surfactant models by gold nanoparticle pollutants.金纳米颗粒污染物对简化肺表面活性剂模型干扰的分子见解。
Biochim Biophys Acta Biomembr. 2019 Aug 1;1861(8):1458-1467. doi: 10.1016/j.bbamem.2019.06.001. Epub 2019 Jun 10.
9
Computational Studies of Lipid-Wrapped Gold Nanoparticle Transport Through Model Lung Surfactant Monolayers.脂质包裹的金纳米颗粒通过模型肺表面活性剂单层的传输的计算研究。
J Phys Chem B. 2021 Feb 11;125(5):1392-1401. doi: 10.1021/acs.jpcb.0c09518. Epub 2021 Feb 2.
10
Investigation of Drug for Pulmonary Administration-Model Pulmonary Surfactant Monolayer Interactions Using Langmuir-Blodgett Monolayer and Molecular Dynamics Simulation: A Case Study of Ketoprofen.肺部给药药物研究-使用 Langmuir-Blodgett 单层膜和分子动力学模拟研究模型肺表面活性剂单层相互作用:以酮洛芬为例。
Langmuir. 2019 Oct 15;35(41):13452-13460. doi: 10.1021/acs.langmuir.9b02412. Epub 2019 Oct 3.

引用本文的文献

1
and studies of the interaction between glucocorticoid drug mometasone furoate and model lung surfactant monolayer.以及糠酸莫米松糖皮质激素药物与模型肺表面活性剂单层之间相互作用的研究。
RSC Adv. 2025 Feb 26;15(8):5951-5964. doi: 10.1039/d5ra00004a. eCollection 2025 Feb 19.
2
The concentration-dependent effect of hydrocortisone on the structure of model lung surfactant monolayer by using an approach.采用一种方法研究氢化可的松对模型肺表面活性剂单层结构的浓度依赖性效应。
RSC Adv. 2022 Nov 22;12(51):33313-33328. doi: 10.1039/d2ra05268g. eCollection 2022 Nov 15.
3
Molecular basis of transport of surface functionalised gold nanoparticles to pulmonary surfactant.
表面功能化金纳米颗粒向肺表面活性剂转运的分子基础
RSC Adv. 2022 Jun 17;12(28):18012-18021. doi: 10.1039/d2ra01892f. eCollection 2022 Jun 14.